✦ LIBER ✦

The safety and efficacy of apixaban: where do we stand in 2013?

✍ Scribed by de Souza Brito, Flavio; Lopes, Renato D; Alexander, John H

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Issue of Statin Safety: Where do We

✍ Grundy, S. M. 📂 Article 📅 2005 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 314 KB

Weak D phenotypes and transfusion safety

✍ France Noizat-Pirenne; Martine Verdier; Annette Lejealle; Anne Mercadier; Philip 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 202 KB

The neuropathology of autism: where do w

✍ C. Schmitz; P. Rezaie 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

The role of vitamin D deficiency in card

✍ Pilz, Stefan; Gaksch, Martin; O’Hartaigh, Bríain; Tomaschitz, Andreas; März, Win 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 771 KB

Protection Orders in the European Member

✍ Suzan van der Aa 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 241 KB

The failure of biologics in sepsis: wher

✍ Giamarellos-Bourboulis, Evangelos J. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 378 KB